Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Aug 06, 2020 7:00am EDT

Recro to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020

Jun 11, 2020 10:00am EDT

Recro Highlights Manufacturing Readiness For Essential Drugs and Medical Supplies

May 11, 2020 7:00am EDT

Recro Reports First Quarter 2020 Financial Results and Provides Update on COVID-19 Response and Impact

May 08, 2020 7:00am EDT

Recro to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 11, 2020

May 01, 2020 4:05pm EDT

Recro Announces Change in Location of its 2020 Annual Meeting of Shareholders to its Corporate Headquarters

Mar 04, 2020 7:00am EST

Recro Reports Financial Results for the Year Ended 2019

Mar 02, 2020 7:00am EST

Recro to Report Year End 2019 Financial Results and Host Conference Call and Webcast on March 4, 2020

Nov 21, 2019 4:30pm EST

Recro Completes Separation of Baudax Bio and Becomes a Dedicated Contract Development and Manufacturing Organization

Nov 21, 2019 7:00am EST

Baudax Bio™ Launches as a New Pharmaceutical Company Aimed at Advancing Promising, Non-Opioid Analgesic Therapies

Nov 13, 2019 7:00am EST

Recro Pharma Announces Effectiveness of Baudax Bio Form 10 Registration Statement

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us